Fully automated bladder tumor segmentation from T2 MRI images using 3D U-Net algorithm

Introduction Bladder magnetic resonance imaging (MRI) has been recently integrated in the diagnosis pathway of bladder cancer. However, automatic recognition of suspicious lesions is still challenging. Thus, development of a solution for proper delimitation of the tumor and its separation from the healthy tissue is of primordial importance. As a solution to this unmet medical need, we aimed to develop an artificial intelligence-based decision support system, which automatically segments the bladder wall and the tumor as well as any suspect area from the 3D MRI images. Materials We retrospectively assessed all patients diagnosed with bladder cancer, who underwent MRI at our department (n=33). All examinations were performed using a 1.5 Tesla MRI scanner. All images were reviewed by two radiologists, who performed manual segmentation of the bladder wall and all lesions. First, the performance of our fully automated end-to-end segmentation model based on a 3D U-Net architecture (by considering various depths of 4, 5 or 6 blocks) trained in two data augmentation scenarios (on 5 and 10 augmentation datasets per original data, respectively) was tested. Second, two learning setups were analyzed by training the segmentation algorithm with 7 and 14 MRI original volumes, respectively. Results We obtained a Dice-based performance over 0.878 for automatic segmentation of bladder wall and tumors, as compared to manual segmentation. A larger training dataset using 10 augmentations for 7 patients could further improve the results of the U-Net-5 model (0.902 Dice coefficient at image level). This model performed best in terms of automated segmentation of bladder, as compared to U-Net-4 and U-Net-6. However, in this case increased time for learning was needed as compared to U-Net-4. We observed that an extended dataset for training led to significantly improved segmentation of the bladder wall, but not of the tumor. Conclusion We developed an intelligent system for bladder tumors automated diagnostic, that uses a deep learning model to segment both the bladder wall and the tumor. As a conclusion, low complexity networks, with less than five-layers U-Net architecture are feasible and show good performance for automatic 3D MRI image segmentation in patients with bladder tumors.

[1]  Sicong Wang,et al.  Development of a MRI-Based Radiomics Nomogram for Prediction of Response of Patients With Muscle-Invasive Bladder Cancer to Neoadjuvant Chemotherapy , 2022, Frontiers in Oncology.

[2]  Sijuan Huang,et al.  Integrating multiple MRI sequences for pelvic organs segmentation via the attention mechanism. , 2021, Medical physics.

[3]  D. Koh,et al.  Automatic Segmentation of Pelvic Cancers Using Deep Learning: State-of-the-Art Approaches and Challenges , 2021, Diagnostics.

[4]  Baojuan Li,et al.  Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer , 2021, Frontiers in Oncology.

[5]  M. Mossanen The Epidemiology of Bladder Cancer. , 2021, Hematology/oncology clinics of North America.

[6]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[7]  Tianyuan Xu,et al.  Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer , 2020, Frontiers in Oncology.

[8]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[9]  V. Panebianco,et al.  Staging of bladder cancer with multiparametric MRI. , 2020, The British journal of radiology.

[10]  F. Khalifa,et al.  A Deep Learning-Based Approach for Accurate Segmentation of Bladder Wall using MR Images , 2019, 2019 IEEE International Conference on Imaging Systems and Techniques (IST).

[11]  A. Weiner,et al.  Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study. , 2019, European urology oncology.

[12]  Guoping Qiu,et al.  Bladder Cancer Multi-Class Segmentation in MRI With Pyramid-In-Pyramid Network , 2019, 2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019).

[13]  C. Catalano,et al.  Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center , 2019, European Radiology.

[14]  R. Sylvester,et al.  Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review. , 2018, European urology.

[15]  Jing Yuan,et al.  Multiregion segmentation of bladder cancer structures in MRI with progressive dilated convolutional networks , 2018, Medical physics.

[16]  Tianshuai Liu,et al.  Three-dimensional texture features from intensity and high-order derivative maps for the discrimination between bladder tumors and wall tissues via MRI , 2017, International Journal of Computer Assisted Radiology and Surgery.

[17]  Konstantinos Kamnitsas,et al.  Efficient multi‐scale 3D CNN with fully connected CRF for accurate brain lesion segmentation , 2016, Medical Image Anal..

[18]  Zhengrong Liang,et al.  Characterization of texture features of bladder carcinoma and the bladder wall on MRI: initial experience. , 2013, Academic radiology.

[19]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[20]  Ben Glocker,et al.  Deformable medical image registration: setting the state of the art with discrete methods. , 2011, Annual review of biomedical engineering.

[21]  C. A. Ninan,et al.  Complications of transurethral resection of bladder tumors: prevention, recognition and treatment. , 1980, The Journal of urology.